Regeneron announces EYLEA(R) (aflibercept) injection approved in Japan
Regeneron announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, has received approval from the Japanese Ministry of Health, Labour and Welfare for EYLEAź (aflibercept) Injection for myopic choroidal neovascularization. September 22, 2014